A clinical trial titled "Gestational Response, Outcomes, and Weight After GLP-1 Use" was listed as recruiting as of August 4, 2026. The study is registered under identifier NCT07743567 on ClinicalTrials.gov. This update is associated with glucagon, an approved compound. No phase information was provided for this trial in the available record. The listing indicates the trial's current status as recruiting, meaning it is open to enrolling participants at this time. No outcomes, results, or efficacy data have been posted for this study as of this update. No information about safety findings or adverse events is included in this record. This brief reflects only the recruiting status and title as registered on the given date. Readers seeking further detail on trial design, eligibility, or enrollment criteria should consult the official ClinicalTrials.gov listing directly. For additional background on glucagon as a compound, readers can consult the compound overview.
Glucagon-Related Trial "GLP-1 Use in Pregnancy" Now Recruiting
See the full glucagon overview
Source: https://clinicaltrials.gov/study/NCT07743567